These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
1057 related articles for article (PubMed ID: 26297071)
21. Pan-retinal photocoagulation and other forms of laser treatment and drug therapies for non-proliferative diabetic retinopathy: systematic review and economic evaluation. Royle P; Mistry H; Auguste P; Shyangdan D; Freeman K; Lois N; Waugh N Health Technol Assess; 2015 Jul; 19(51):v-xxviii, 1-247. PubMed ID: 26173799 [TBL] [Abstract][Full Text] [Related]
22. Retinal function in eyes with proliferative diabetic retinopathy treated with intravitreal ranibizumab and multispot laser panretinal photocoagulation. Messias K; Barroso RM; Jorge R; Messias A Doc Ophthalmol; 2018 Oct; 137(2):121-129. PubMed ID: 30209775 [TBL] [Abstract][Full Text] [Related]
29. The area of fixation covaries with short-term changes in visual acuity after anti-vascular endothelial growth factor treatment in patients with diabetic macular oedema. Jakobsen NS; Larsen DA; Bek T Acta Ophthalmol; 2018 Nov; 96(7):744-748. PubMed ID: 29687595 [TBL] [Abstract][Full Text] [Related]
30. A review of therapies for diabetic macular oedema and rationale for combination therapy. Amoaku WM; Saker S; Stewart EA Eye (Lond); 2015 Sep; 29(9):1115-30. PubMed ID: 26113500 [TBL] [Abstract][Full Text] [Related]
31. Targeted Retinal Photocoagulation for Diabetic Macular Edema with Peripheral Retinal Nonperfusion: Three-Year Randomized DAVE Trial. Brown DM; Ou WC; Wong TP; Kim RY; Croft DE; Wykoff CC; Ophthalmology; 2018 May; 125(5):683-690. PubMed ID: 29336896 [TBL] [Abstract][Full Text] [Related]
37. Optical coherence tomography angiography analysis of macular vessel density before and after anti-VEGF therapy in eyes with diabetic retinopathy. Sorour OA; Sabrosa AS; Yasin Alibhai A; Arya M; Ishibazawa A; Witkin AJ; Baumal CR; Duker JS; Waheed NK Int Ophthalmol; 2019 Oct; 39(10):2361-2371. PubMed ID: 31119505 [TBL] [Abstract][Full Text] [Related]
38. Trends of Anti-Vascular Endothelial Growth Factor Use in Ophthalmology Among Privately Insured and Medicare Advantage Patients. Parikh R; Ross JS; Sangaralingham LR; Adelman RA; Shah ND; Barkmeier AJ Ophthalmology; 2017 Mar; 124(3):352-358. PubMed ID: 27890437 [TBL] [Abstract][Full Text] [Related]
39. Comparison of Aflibercept, Bevacizumab, and Ranibizumab for Treatment of Diabetic Macular Edema: Extrapolation of Data to Clinical Practice. Heier JS; Bressler NM; Avery RL; Bakri SJ; Boyer DS; Brown DM; Dugel PU; Freund KB; Glassman AR; Kim JE; Martin DF; Pollack JS; Regillo CD; Rosenfeld PJ; Schachat AP; Wells JA; JAMA Ophthalmol; 2016 Jan; 134(1):95-9. PubMed ID: 26512939 [TBL] [Abstract][Full Text] [Related]